Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Australia |
First Approval Date01 Jul 2004 |
100 Clinical Results associated with Bayer AB
0 Patents (Medical) associated with Bayer AB
100 Deals associated with Bayer AB
100 Translational Medicine associated with Bayer AB